Flowserve Corporation (NYSE: FLS) (“Flowserve”), a leading provider of flow control products and services for the global infrastructure markets, today announced it has terminated its previously ...

Headwaters Capital sees deep value in Bio-Techne as academic cuts weigh on shares. Learn why this life sciences leader could ...

Hims & Hers is a top telehealth stock with strong revenue growth, innovative offerings, and long-term potential. Click here ...

Q2 2025 Earnings Call Transcript August 7, 2025 Operator: Good day, and thank you for standing by. Welcome to the Arcutis ...

Overview of Cell Isolation MarketThe global Cell Isolation Market is valued at USD 15.6 Billion in 2024 and is projected to reach a value of USD 60.56 Billion by 2035 at a CAGR (Compound Annual Growth ...

A collection of articles, podcasts & tweets from around the web to keep you in touch with the Commanders, the NFC East, the NFL and sports in general, and a sprinkling of other stuff ...

Buy the Dip investors will lover IBM’s drop on strong earnings, while value investors should look at Boeing’s setup for a ...

Detailed price information for Catalyst Pharm Inc (CPRX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Aldeyra Therapeu (ALDX-Q) from The Globe and Mail including charting and trades.

The FDA in 2022 announced a ban on the sale of Juul e-cigarettes nationwide, saying the company did not prove that keeping its products on the market “would be appropriate for the protection of ...

The manufacturing-related rejection also delays a key test of the new FDA leadership’s support for cell and gene therapy against rare diseases.

FDA panel on the use of antidepressants during pregnancy is alarming experts The U.S. Food and Drug Administration campus in Silver Spring, Md. (Andrew Harnik / Associated Press) ...